Heron Therapeutics HRTX 深 滬
已收盤 09-20 16:00:00 美东时间
2.06
+0.040
+1.98%
華盛通- 最 高2.06
- 今 開2.02
- 成交量 672.43万股
- 最 低 1.93
- 昨 收 2.02
- 總市值 3.09亿
- 52周最高 3.93
- 市盈率 靜 --
- 換手率 4.48%
- 52周最低 0.50
- 委 比 29.05%
- 總股本 1.50亿
- 歷史最高 42.90
- 量 比 3.17
- 振 幅 6.44%
- 歷史最低 0.50
- 每 手 1
- 風險率 0.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Heron Therapeutics Insider Buyers Net US$332k Despite 29% Stock Decline
Insiders who bought Heron Therapeutics, Inc. (NASDAQ:HRTX) in the last 12 month...
08-08 20:11
Needham Reiterates Buy on Heron Therapeutics, Maintains $5 Price Target
Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $5 price target.
08-07 18:21
Heron Therapeutics Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-07 18:20
Heron Therapeutics: Poised for Profitability Amid Growth Catalysts
Heron Therapeutics (HRTX – Research Report), the Healthcare sector company, was...
08-07 17:55
快讯 | Heron Therapeutics公司预计FY产品收入为1.38亿至1.58亿美元。
Heron Therapeutics Inc Sees FY Product Revenues $138.0 to $158.0 Million
08-07 04:44
Heron Therapeutics Q2 2024 GAAP EPS $(0.06) Misses $(0.04) Estimate, Sales $36.024M Beat $35.888M Estimate
Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.06) per share...
08-07 04:17
快讯 | heron therapeutics第二季度营业收入美元指数为-644.5万
Heron Therapeutics Q2 Income From Operations USD -6.445 Million
08-07 04:05
快讯 | heron therapeutics第二季度净利润为美元指数-923.5万。
Heron Therapeutics Q2 Net Income USD -9.235 Million
08-07 04:05
快讯 | Heron Therapeutics宣布，Zynrelef®将被列为2025年止疼非阿片类政策和Opps和Asc支付系统下的合格产品。
Heron Therapeutics Announces the Inclusion of Zynrelef® as a Qualifying Product...
07-15 20:01
